Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.58941358 |
2 | modulation by symbiont of host immune response (GO:0052553) | 5.58941358 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.58941358 |
4 | modulation by symbiont of host defense response (GO:0052031) | 5.58941358 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.58941358 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.58941358 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91155500 |
8 | nuclear pore complex assembly (GO:0051292) | 4.76965865 |
9 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 4.48272725 |
10 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.45952956 |
11 | regulation of gene silencing by miRNA (GO:0060964) | 4.45952956 |
12 | regulation of gene silencing by RNA (GO:0060966) | 4.45952956 |
13 | nuclear pore organization (GO:0006999) | 4.38666379 |
14 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.29677684 |
15 | mitotic G2/M transition checkpoint (GO:0044818) | 4.22870621 |
16 | mitotic G2 DNA damage checkpoint (GO:0007095) | 4.19092521 |
17 | microglial cell activation (GO:0001774) | 4.17278830 |
18 | mitotic sister chromatid cohesion (GO:0007064) | 4.13784766 |
19 | macrophage activation involved in immune response (GO:0002281) | 4.10429311 |
20 | neutrophil activation involved in immune response (GO:0002283) | 4.07756945 |
21 | endothelium development (GO:0003158) | 4.05791698 |
22 | negative regulation of DNA repair (GO:0045738) | 3.96003344 |
23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91685414 |
24 | response to host immune response (GO:0052572) | 3.87498052 |
25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.87498052 |
26 | pre-miRNA processing (GO:0031054) | 3.85088349 |
27 | response to peptidoglycan (GO:0032494) | 3.82941095 |
28 | positive regulation of interferon-alpha production (GO:0032727) | 3.73290098 |
29 | labyrinthine layer development (GO:0060711) | 3.58661381 |
30 | neutrophil activation (GO:0042119) | 3.57748153 |
31 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55122427 |
32 | response to host (GO:0075136) | 3.55122427 |
33 | response to host defenses (GO:0052200) | 3.55122427 |
34 | regulation of interferon-alpha production (GO:0032647) | 3.52720766 |
35 | neutrophil mediated immunity (GO:0002446) | 3.52087567 |
36 | germinal center formation (GO:0002467) | 3.50179882 |
37 | response to muramyl dipeptide (GO:0032495) | 3.49270483 |
38 | response to hydroperoxide (GO:0033194) | 3.48911723 |
39 | I-kappaB phosphorylation (GO:0007252) | 3.47293635 |
40 | regulation of histone H3-K9 methylation (GO:0051570) | 3.45189598 |
41 | pore complex assembly (GO:0046931) | 3.43940388 |
42 | superoxide anion generation (GO:0042554) | 3.43573708 |
43 | granulocyte activation (GO:0036230) | 3.42369115 |
44 | response to X-ray (GO:0010165) | 3.40134702 |
45 | positive regulation of heat generation (GO:0031652) | 3.37479257 |
46 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.35274799 |
47 | CENP-A containing nucleosome assembly (GO:0034080) | 3.35254655 |
48 | chromatin remodeling at centromere (GO:0031055) | 3.33531402 |
49 | anterior/posterior axis specification, embryo (GO:0008595) | 3.31396043 |
50 | detection of molecule of bacterial origin (GO:0032490) | 3.31387157 |
51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30293266 |
52 | macrophage activation (GO:0042116) | 3.28409262 |
53 | nodal signaling pathway (GO:0038092) | 3.26154264 |
54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.22627200 |
55 | regulation of meiosis I (GO:0060631) | 3.22492326 |
56 | cellular extravasation (GO:0045123) | 3.22334270 |
57 | regulation of helicase activity (GO:0051095) | 3.20230426 |
58 | histone exchange (GO:0043486) | 3.17831433 |
59 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.15929219 |
60 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.15437904 |
61 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.13905598 |
62 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.13905598 |
63 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.12003293 |
64 | negative regulation of granulocyte differentiation (GO:0030853) | 3.10065673 |
65 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06948299 |
66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06899666 |
67 | negative regulation of interleukin-12 production (GO:0032695) | 3.06315344 |
68 | myeloid cell activation involved in immune response (GO:0002275) | 3.05734884 |
69 | respiratory burst (GO:0045730) | 3.03930453 |
70 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.99637100 |
71 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.99637100 |
72 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.99637100 |
73 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.99105223 |
74 | regulation of establishment of cell polarity (GO:2000114) | 2.94284543 |
75 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.94224719 |
76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92110634 |
77 | regulation of fever generation (GO:0031620) | 2.91625142 |
78 | regulation of mast cell degranulation (GO:0043304) | 2.90803286 |
79 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.84433085 |
80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83952045 |
81 | immunoglobulin mediated immune response (GO:0016064) | 2.83527163 |
82 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.80544842 |
83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80280106 |
84 | transcytosis (GO:0045056) | 2.78223146 |
85 | mitotic metaphase plate congression (GO:0007080) | 2.77073688 |
86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77008245 |
87 | negative regulation of cell killing (GO:0031342) | 2.77008245 |
88 | primitive streak formation (GO:0090009) | 2.76438858 |
89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76426100 |
90 | glomerular visceral epithelial cell development (GO:0072015) | 2.76127246 |
91 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75913998 |
92 | regulation of chromatin silencing (GO:0031935) | 2.75586096 |
93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.73924758 |
94 | positive regulation of mast cell degranulation (GO:0043306) | 2.73924758 |
95 | regulation of gene silencing (GO:0060968) | 2.72470402 |
96 | phospholipid scrambling (GO:0017121) | 2.72030745 |
97 | regulation of integrin activation (GO:0033623) | 2.71745505 |
98 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.71642551 |
99 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.70947727 |
100 | non-recombinational repair (GO:0000726) | 2.70947727 |
101 | glomerular epithelial cell development (GO:0072310) | 2.70256647 |
102 | polyketide metabolic process (GO:0030638) | 2.70165450 |
103 | doxorubicin metabolic process (GO:0044598) | 2.70165450 |
104 | daunorubicin metabolic process (GO:0044597) | 2.70165450 |
105 | positive regulation of catenin import into nucleus (GO:0035413) | 2.69425967 |
106 | interkinetic nuclear migration (GO:0022027) | 2.69336084 |
107 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.67869972 |
108 | positive regulation of interferon-beta production (GO:0032728) | 2.66973819 |
109 | histone H3-K4 trimethylation (GO:0080182) | 2.66403981 |
110 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65384590 |
111 | regulation of mesoderm development (GO:2000380) | 2.65195069 |
112 | embryonic process involved in female pregnancy (GO:0060136) | 2.63705673 |
113 | negative regulation of lipid storage (GO:0010888) | 2.63562983 |
114 | positive regulation of protein autophosphorylation (GO:0031954) | 2.62911967 |
115 | cellular response to zinc ion (GO:0071294) | 2.61899639 |
116 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61447698 |
117 | phagocytosis, engulfment (GO:0006911) | 2.61267302 |
118 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61233826 |
119 | regulation of mononuclear cell migration (GO:0071675) | 2.60949179 |
120 | regulation of mast cell activation (GO:0033003) | 2.59854797 |
121 | cytokine secretion (GO:0050663) | 2.59767945 |
122 | definitive hemopoiesis (GO:0060216) | 2.59673933 |
123 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.58831935 |
124 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.57720579 |
125 | monocyte chemotaxis (GO:0002548) | 2.57693435 |
126 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.56897238 |
127 | leukocyte aggregation (GO:0070486) | 2.54898807 |
128 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.54263707 |
129 | IMP metabolic process (GO:0046040) | 2.54087920 |
130 | regulation of heat generation (GO:0031650) | 2.54052571 |
131 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.53741434 |
132 | metaphase plate congression (GO:0051310) | 2.53450511 |
133 | detection of other organism (GO:0098543) | 2.52998488 |
134 | IMP biosynthetic process (GO:0006188) | 2.52531670 |
135 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.52487428 |
136 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.52487428 |
137 | ncRNA catabolic process (GO:0034661) | 2.52035271 |
138 | regulation of antigen processing and presentation (GO:0002577) | 2.51893086 |
139 | B cell homeostasis (GO:0001782) | 2.51261243 |
140 | lactate metabolic process (GO:0006089) | 2.50766964 |
141 | pinocytosis (GO:0006907) | 2.50687923 |
142 | regulation of leukocyte degranulation (GO:0043300) | 2.50209086 |
143 | protein localization to kinetochore (GO:0034501) | 2.49436221 |
144 | myeloid leukocyte activation (GO:0002274) | 2.48803131 |
145 | G-protein coupled receptor internalization (GO:0002031) | 2.48789771 |
146 | positive regulation of mast cell activation (GO:0033005) | 2.48674007 |
147 | detection of external biotic stimulus (GO:0098581) | 2.48213679 |
148 | response to interferon-alpha (GO:0035455) | 2.47781943 |
149 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.47384118 |
150 | modulation by symbiont of host cellular process (GO:0044068) | 2.46993693 |
151 | regulation of cell fate specification (GO:0042659) | 2.44993217 |
152 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.44328567 |
153 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.44297776 |
154 | DNA replication-independent nucleosome organization (GO:0034724) | 2.44297776 |
155 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.44289561 |
156 | regulation of hypersensitivity (GO:0002883) | 2.43479753 |
157 | regulation of DNA endoreduplication (GO:0032875) | 2.43287728 |
158 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43148802 |
159 | N-terminal protein amino acid acetylation (GO:0006474) | 2.42254918 |
160 | synapsis (GO:0007129) | 2.41355129 |
161 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.40232001 |
162 | sister chromatid cohesion (GO:0007062) | 2.39423231 |
163 | negative regulation of mast cell activation (GO:0033004) | 2.38787680 |
164 | replicative senescence (GO:0090399) | 2.38628284 |
165 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.38326859 |
166 | natural killer cell mediated immunity (GO:0002228) | 2.38326859 |
167 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.38225155 |
168 | detection of biotic stimulus (GO:0009595) | 2.38007846 |
169 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.37879952 |
170 | positive regulation of interleukin-12 production (GO:0032735) | 2.37795390 |
171 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.37717410 |
172 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.37717410 |
173 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.37717410 |
174 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.37717410 |
175 | negative regulation of sister chromatid segregation (GO:0033046) | 2.37717410 |
176 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.37166137 |
177 | response to type I interferon (GO:0034340) | 2.36641906 |
178 | histone mRNA catabolic process (GO:0071044) | 2.35710900 |
179 | regulation of DNA methylation (GO:0044030) | 2.34733523 |
180 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.34708224 |
181 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.34708224 |
182 | regulation of sister chromatid segregation (GO:0033045) | 2.34708224 |
183 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.34613557 |
184 | type I interferon signaling pathway (GO:0060337) | 2.33987107 |
185 | determination of adult lifespan (GO:0008340) | 2.33906110 |
186 | cellular response to ethanol (GO:0071361) | 2.33590040 |
187 | female gonad development (GO:0008585) | 2.32649282 |
188 | lymphangiogenesis (GO:0001946) | 2.31627191 |
189 | protein complex localization (GO:0031503) | 2.30547569 |
190 | ribosome assembly (GO:0042255) | 2.29905483 |
191 | toxin transport (GO:1901998) | 2.29651338 |
192 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.28987207 |
193 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.28987207 |
194 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.28987207 |
195 | cell migration involved in gastrulation (GO:0042074) | 2.28830639 |
196 | prenylation (GO:0097354) | 2.28203086 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.29067376 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.26917020 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12171392 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.94024484 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.75816436 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.30072547 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.22435915 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17057842 |
9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.16387786 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13256440 |
11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.83805519 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78722944 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48793548 |
14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.47145716 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.46792008 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39498337 |
17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21715117 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.03196859 |
19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.98681505 |
20 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.94794242 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91379062 |
22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.90466190 |
23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89266593 |
24 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85994215 |
25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83820584 |
26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78552099 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75870771 |
28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.75316101 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74116419 |
30 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.74108923 |
31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74042006 |
32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72023525 |
33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.69963417 |
34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68784651 |
35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63928461 |
36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.63587193 |
37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61350171 |
38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.59424129 |
39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.58930139 |
40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57123749 |
41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55015818 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51910755 |
43 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.46006598 |
44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43700421 |
45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41954795 |
46 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.39660455 |
47 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.39340000 |
48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38446531 |
49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38029172 |
50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34357293 |
51 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30483411 |
52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29917282 |
53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29615209 |
54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29198736 |
55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28167213 |
56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27359076 |
57 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.25293808 |
58 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.23900743 |
59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21633639 |
60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21520872 |
61 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18731028 |
62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18179422 |
63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17280305 |
64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17092223 |
65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17015514 |
66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16335284 |
67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16136997 |
68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15403492 |
69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15196087 |
70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15006990 |
71 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14289577 |
72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13759340 |
73 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13615238 |
74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10177055 |
75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10177055 |
76 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09703669 |
77 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08980763 |
78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08980763 |
79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08606668 |
80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08586685 |
81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08084962 |
82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08078377 |
83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07721534 |
84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07142124 |
85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07120362 |
86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07092501 |
87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06751847 |
88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06516065 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06316388 |
90 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06265615 |
91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05093070 |
92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04660126 |
93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04615198 |
94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04017938 |
95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04017938 |
96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03957002 |
97 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03725877 |
98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03589433 |
99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03581253 |
100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02435768 |
101 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02355241 |
102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02307129 |
103 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01024319 |
104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.00754781 |
105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00292074 |
106 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00046244 |
107 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99651215 |
108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99201263 |
109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99138949 |
110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99003843 |
111 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98793518 |
112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98260144 |
113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98116312 |
114 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97785743 |
115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97748715 |
116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97704812 |
117 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97704812 |
118 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.97622266 |
119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97416676 |
120 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.97027717 |
121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96578698 |
122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95100394 |
123 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95006930 |
124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94063352 |
125 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93432360 |
126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93421468 |
127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92549863 |
128 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92272185 |
129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.92137015 |
130 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.91359593 |
131 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91335619 |
132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91171793 |
133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91142969 |
134 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.90446288 |
135 | MYB_26560356_Chip-Seq_TH1_Human | 0.90349474 |
136 | MYB_26560356_Chip-Seq_TH2_Human | 0.90201197 |
137 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89767475 |
138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88997731 |
139 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88647280 |
140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88615589 |
141 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.87958103 |
142 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87771469 |
143 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87695443 |
144 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86944166 |
145 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.86744578 |
146 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.86684963 |
147 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.86684963 |
148 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.86684963 |
149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85840702 |
150 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85770539 |
151 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.85591340 |
152 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85007482 |
153 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84230920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 5.10321184 |
2 | MP0010352_gastrointestinal_tract_polyps | 3.53307246 |
3 | MP0001835_abnormal_antigen_presentation | 3.39124842 |
4 | MP0003941_abnormal_skin_development | 3.23257741 |
5 | MP0003890_abnormal_embryonic-extraembry | 3.04193401 |
6 | MP0002419_abnormal_innate_immunity | 2.92934822 |
7 | MP0003436_decreased_susceptibility_to | 2.82901003 |
8 | MP0003172_abnormal_lysosome_physiology | 2.58916610 |
9 | MP0003724_increased_susceptibility_to | 2.56624209 |
10 | MP0009697_abnormal_copulation | 2.53706891 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.52456049 |
12 | MP0006054_spinal_hemorrhage | 2.51434690 |
13 | MP0004510_myositis | 2.48884794 |
14 | MP0006082_CNS_inflammation | 2.46610698 |
15 | MP0003303_peritoneal_inflammation | 2.35549710 |
16 | MP0005387_immune_system_phenotype | 2.34487993 |
17 | MP0001790_abnormal_immune_system | 2.34487993 |
18 | MP0010368_abnormal_lymphatic_system | 2.32897213 |
19 | MP0009785_altered_susceptibility_to | 2.26498298 |
20 | MP0005000_abnormal_immune_tolerance | 2.25596531 |
21 | MP0005058_abnormal_lysosome_morphology | 2.23349829 |
22 | MP0002452_abnormal_antigen_presenting | 2.22258170 |
23 | MP0005025_abnormal_response_to | 2.18828645 |
24 | MP0002006_tumorigenesis | 2.10480776 |
25 | MP0005464_abnormal_platelet_physiology | 2.06542407 |
26 | MP0001800_abnormal_humoral_immune | 2.05424862 |
27 | MP0002166_altered_tumor_susceptibility | 2.00920553 |
28 | MP0002723_abnormal_immune_serum | 2.00799120 |
29 | MP0009278_abnormal_bone_marrow | 2.00093356 |
30 | MP0003045_fibrosis | 1.99190300 |
31 | MP0005174_abnormal_tail_pigmentation | 1.98188433 |
32 | MP0004957_abnormal_blastocyst_morpholog | 1.98010527 |
33 | MP0003950_abnormal_plasma_membrane | 1.97659036 |
34 | MP0005671_abnormal_response_to | 1.97617847 |
35 | MP0003183_abnormal_peptide_metabolism | 1.96459792 |
36 | MP0003828_pulmonary_edema | 1.91413632 |
37 | MP0000685_abnormal_immune_system | 1.91051020 |
38 | MP0001879_abnormal_lymphatic_vessel | 1.89541475 |
39 | MP0003300_gastrointestinal_ulcer | 1.86019585 |
40 | MP0003195_calcinosis | 1.85670988 |
41 | MP0002998_abnormal_bone_remodeling | 1.80799874 |
42 | MP0001819_abnormal_immune_cell | 1.78889820 |
43 | MP0010094_abnormal_chromosome_stability | 1.77883547 |
44 | MP0004272_abnormal_basement_membrane | 1.77481883 |
45 | MP0002420_abnormal_adaptive_immunity | 1.75417799 |
46 | MP0000015_abnormal_ear_pigmentation | 1.71894912 |
47 | MP0002254_reproductive_system_inflammat | 1.70903373 |
48 | MP0001533_abnormal_skeleton_physiology | 1.70711760 |
49 | MP0009764_decreased_sensitivity_to | 1.69814071 |
50 | MP0003718_maternal_effect | 1.65782732 |
51 | MP0001853_heart_inflammation | 1.60738188 |
52 | MP0004084_abnormal_cardiac_muscle | 1.58698791 |
53 | MP0003448_altered_tumor_morphology | 1.57779739 |
54 | MP0002405_respiratory_system_inflammati | 1.57570534 |
55 | MP0002396_abnormal_hematopoietic_system | 1.56958239 |
56 | MP0002009_preneoplasia | 1.50693200 |
57 | MP0000371_diluted_coat_color | 1.47241038 |
58 | MP0004947_skin_inflammation | 1.46461186 |
59 | MP0003191_abnormal_cellular_cholesterol | 1.45824066 |
60 | MP0008877_abnormal_DNA_methylation | 1.45423938 |
61 | MP0001845_abnormal_inflammatory_respons | 1.42993159 |
62 | MP0000343_altered_response_to | 1.39435643 |
63 | MP0005171_absent_coat_pigmentation | 1.37636647 |
64 | MP0003566_abnormal_cell_adhesion | 1.36628955 |
65 | MP0010234_abnormal_vibrissa_follicle | 1.36345843 |
66 | MP0002277_abnormal_respiratory_mucosa | 1.36157359 |
67 | MP0001545_abnormal_hematopoietic_system | 1.32892192 |
68 | MP0005397_hematopoietic_system_phenotyp | 1.32892192 |
69 | MP0003077_abnormal_cell_cycle | 1.32341781 |
70 | MP0003075_altered_response_to | 1.32247097 |
71 | MP0005380_embryogenesis_phenotype | 1.31569060 |
72 | MP0001672_abnormal_embryogenesis/_devel | 1.31569060 |
73 | MP0010155_abnormal_intestine_physiology | 1.29879542 |
74 | MP0009672_abnormal_birth_weight | 1.28266494 |
75 | MP0003984_embryonic_growth_retardation | 1.27497216 |
76 | MP0001661_extended_life_span | 1.26654525 |
77 | MP0001851_eye_inflammation | 1.26261776 |
78 | MP0002088_abnormal_embryonic_growth/wei | 1.26097620 |
79 | MP0002928_abnormal_bile_duct | 1.24842659 |
80 | MP0005076_abnormal_cell_differentiation | 1.24041014 |
81 | MP0004036_abnormal_muscle_relaxation | 1.23540553 |
82 | MP0000716_abnormal_immune_system | 1.22519781 |
83 | MP0008058_abnormal_DNA_repair | 1.22302502 |
84 | MP0005075_abnormal_melanosome_morpholog | 1.20909632 |
85 | MP0003690_abnormal_glial_cell | 1.20115215 |
86 | MP0008469_abnormal_protein_level | 1.18965760 |
87 | MP0008438_abnormal_cutaneous_collagen | 1.18286212 |
88 | MP0008007_abnormal_cellular_replicative | 1.18205893 |
89 | MP0002086_abnormal_extraembryonic_tissu | 1.17908009 |
90 | MP0005670_abnormal_white_adipose | 1.17533990 |
91 | MP0001730_embryonic_growth_arrest | 1.16230327 |
92 | MP0005395_other_phenotype | 1.16097823 |
93 | MP0003453_abnormal_keratinocyte_physiol | 1.12998028 |
94 | MP0010678_abnormal_skin_adnexa | 1.12514727 |
95 | MP0005257_abnormal_intraocular_pressure | 1.11964784 |
96 | MP0003868_abnormal_feces_composition | 1.10340932 |
97 | MP0002398_abnormal_bone_marrow | 1.09486219 |
98 | MP0000767_abnormal_smooth_muscle | 1.09393036 |
99 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06836648 |
100 | MP0002796_impaired_skin_barrier | 1.06835319 |
101 | MP0005647_abnormal_sex_gland | 1.05848206 |
102 | MP0010307_abnormal_tumor_latency | 1.05473600 |
103 | MP0002084_abnormal_developmental_patter | 1.04681579 |
104 | MP0005310_abnormal_salivary_gland | 1.04513198 |
105 | MP0003693_abnormal_embryo_hatching | 1.02665209 |
106 | MP0005666_abnormal_adipose_tissue | 1.01916497 |
107 | MP0004215_abnormal_myocardial_fiber | 1.01670635 |
108 | MP0004381_abnormal_hair_follicle | 1.01571191 |
109 | MP0003091_abnormal_cell_migration | 1.00801922 |
110 | MP0005390_skeleton_phenotype | 0.99544466 |
111 | MP0003646_muscle_fatigue | 0.98138761 |
112 | MP0000858_altered_metastatic_potential | 0.97947805 |
113 | MP0005167_abnormal_blood-brain_barrier | 0.96410974 |
114 | MP0001873_stomach_inflammation | 0.94322525 |
115 | MP0001293_anophthalmia | 0.93977043 |
116 | MP0002933_joint_inflammation | 0.93489131 |
117 | MP0005164_abnormal_response_to | 0.92527606 |
118 | MP0000689_abnormal_spleen_morphology | 0.92309418 |
119 | MP0004264_abnormal_extraembryonic_tissu | 0.91836656 |
120 | MP0003111_abnormal_nucleus_morphology | 0.90717922 |
121 | MP0002332_abnormal_exercise_endurance | 0.90611926 |
122 | MP0008004_abnormal_stomach_pH | 0.89861867 |
123 | MP0004782_abnormal_surfactant_physiolog | 0.89750930 |
124 | MP0009703_decreased_birth_body | 0.89552419 |
125 | MP0003279_aneurysm | 0.88925595 |
126 | MP0000383_abnormal_hair_follicle | 0.87374148 |
127 | MP0002925_abnormal_cardiovascular_devel | 0.87224960 |
128 | MP0002429_abnormal_blood_cell | 0.87082063 |
129 | MP0002168_other_aberrant_phenotype | 0.86704308 |
130 | MP0004808_abnormal_hematopoietic_stem | 0.86131484 |
131 | MP0000350_abnormal_cell_proliferation | 0.86084733 |
132 | MP0001958_emphysema | 0.86057795 |
133 | MP0001697_abnormal_embryo_size | 0.85764726 |
134 | MP0008057_abnormal_DNA_replication | 0.83655255 |
135 | MP0002722_abnormal_immune_system | 0.81738077 |
136 | MP0003806_abnormal_nucleotide_metabolis | 0.81476994 |
137 | MP0009763_increased_sensitivity_to | 0.81380795 |
138 | MP0005166_decreased_susceptibility_to | 0.81248073 |
139 | MP0010630_abnormal_cardiac_muscle | 0.80902368 |
140 | MP0001666_abnormal_nutrient_absorption | 0.80199066 |
141 | MP0005165_increased_susceptibility_to | 0.79778942 |
142 | MP0003252_abnormal_bile_duct | 0.78376617 |
143 | MP0000249_abnormal_blood_vessel | 0.78111767 |
144 | MP0002060_abnormal_skin_morphology | 0.77074696 |
145 | MP0005023_abnormal_wound_healing | 0.77038706 |
146 | MP0002085_abnormal_embryonic_tissue | 0.76985774 |
147 | MP0002138_abnormal_hepatobiliary_system | 0.75808259 |
148 | MP0000465_gastrointestinal_hemorrhage | 0.74945742 |
149 | MP0008932_abnormal_embryonic_tissue | 0.73654957 |
150 | MP0004484_altered_response_of | 0.73378109 |
151 | MP0002128_abnormal_blood_circulation | 0.73110691 |
152 | MP0005409_darkened_coat_color | 0.72596766 |
153 | MP0003937_abnormal_limbs/digits/tail_de | 0.72204275 |
154 | MP0005266_abnormal_metabolism | 0.71007655 |
155 | MP0003705_abnormal_hypodermis_morpholog | 0.69660654 |
156 | MP0000266_abnormal_heart_morphology | 0.69492011 |
157 | MP0004185_abnormal_adipocyte_glucose | 0.68666184 |
158 | MP0001915_intracranial_hemorrhage | 0.68344402 |
159 | MP0003795_abnormal_bone_structure | 0.67547469 |
160 | MP0000428_abnormal_craniofacial_morphol | 0.67477807 |
161 | MP0001784_abnormal_fluid_regulation | 0.66749101 |
162 | MP0001614_abnormal_blood_vessel | 0.66312036 |
163 | MP0003786_premature_aging | 0.66172693 |
164 | MP0005275_abnormal_skin_tensile | 0.66158989 |
165 | MP0001191_abnormal_skin_condition | 0.66150894 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.01917518 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.70005647 |
3 | Eczematoid dermatitis (HP:0000976) | 5.38340308 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.60148825 |
5 | Hypoglycemic seizures (HP:0002173) | 4.29784768 |
6 | Prostate neoplasm (HP:0100787) | 3.99986237 |
7 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.94914006 |
8 | Embryonal renal neoplasm (HP:0011794) | 3.85928453 |
9 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.65401090 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.65391044 |
11 | Gingivitis (HP:0000230) | 3.59566171 |
12 | Recurrent skin infections (HP:0001581) | 3.45441024 |
13 | Acute myeloid leukemia (HP:0004808) | 3.42819148 |
14 | Abnormality of macrophages (HP:0004311) | 3.33363833 |
15 | Recurrent fungal infections (HP:0002841) | 3.31397766 |
16 | Periodontitis (HP:0000704) | 3.26150153 |
17 | Orchitis (HP:0100796) | 3.24695163 |
18 | Myositis (HP:0100614) | 3.23628304 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.16649494 |
20 | Optic neuritis (HP:0100653) | 3.16649494 |
21 | Colon cancer (HP:0003003) | 3.14066450 |
22 | Thick nail (HP:0001805) | 3.12841802 |
23 | Biliary tract neoplasm (HP:0100574) | 3.06243763 |
24 | Papillary thyroid carcinoma (HP:0002895) | 3.05283420 |
25 | Spastic diplegia (HP:0001264) | 3.04912659 |
26 | Systemic lupus erythematosus (HP:0002725) | 3.01158629 |
27 | Stomatitis (HP:0010280) | 2.94998394 |
28 | Symptomatic seizures (HP:0011145) | 2.94710661 |
29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.90748385 |
30 | Volvulus (HP:0002580) | 2.89748936 |
31 | Rhabdomyosarcoma (HP:0002859) | 2.87584901 |
32 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.86147135 |
33 | Myocardial infarction (HP:0001658) | 2.86032548 |
34 | Absent frontal sinuses (HP:0002688) | 2.84762731 |
35 | Reduced antithrombin III activity (HP:0001976) | 2.82316738 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78268481 |
37 | Obstructive lung disease (HP:0006536) | 2.78268481 |
38 | Axonal loss (HP:0003447) | 2.73000202 |
39 | Hypoglycemic coma (HP:0001325) | 2.71012778 |
40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70508748 |
41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70508748 |
42 | Supernumerary spleens (HP:0009799) | 2.70391047 |
43 | Abnormality of the nasal septum (HP:0000419) | 2.70333987 |
44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69495134 |
45 | B lymphocytopenia (HP:0010976) | 2.67708453 |
46 | Chromsome breakage (HP:0040012) | 2.67510562 |
47 | Chronic bronchitis (HP:0004469) | 2.66664396 |
48 | Abnormality of the prostate (HP:0008775) | 2.61234016 |
49 | Abnormality of B cell number (HP:0010975) | 2.61184991 |
50 | Stenosis of the external auditory canal (HP:0000402) | 2.55969868 |
51 | Thrombocytosis (HP:0001894) | 2.51980263 |
52 | Hematochezia (HP:0002573) | 2.51360251 |
53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.48235023 |
54 | Abnormality of chromosome stability (HP:0003220) | 2.47618226 |
55 | Nemaline bodies (HP:0003798) | 2.44970225 |
56 | Urethral obstruction (HP:0000796) | 2.44060771 |
57 | Sensory axonal neuropathy (HP:0003390) | 2.43223674 |
58 | Neoplasm of the small intestine (HP:0100833) | 2.42786677 |
59 | Conjunctival telangiectasia (HP:0000524) | 2.42141695 |
60 | Recurrent viral infections (HP:0004429) | 2.42068002 |
61 | Vasculitis (HP:0002633) | 2.40453514 |
62 | Vacuolated lymphocytes (HP:0001922) | 2.39603705 |
63 | Osteomyelitis (HP:0002754) | 2.35473465 |
64 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.35161544 |
65 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.35161544 |
66 | Gingival bleeding (HP:0000225) | 2.33593326 |
67 | Gonadotropin excess (HP:0000837) | 2.33409452 |
68 | Abnormality of the frontal sinuses (HP:0002687) | 2.32719845 |
69 | Premature loss of primary teeth (HP:0006323) | 2.32112836 |
70 | Fair hair (HP:0002286) | 2.31806265 |
71 | Abnormality of the fingertips (HP:0001211) | 2.30812576 |
72 | Pustule (HP:0200039) | 2.29089960 |
73 | Recurrent pneumonia (HP:0006532) | 2.26955390 |
74 | Cheilitis (HP:0100825) | 2.26209416 |
75 | Intrahepatic cholestasis (HP:0001406) | 2.24487948 |
76 | Cellulitis (HP:0100658) | 2.24316515 |
77 | Basal ganglia calcification (HP:0002135) | 2.23301639 |
78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22878928 |
79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22878928 |
80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22878928 |
81 | Portal hypertension (HP:0001409) | 2.21599850 |
82 | Autoimmune thrombocytopenia (HP:0001973) | 2.18924526 |
83 | Pulmonary infiltrates (HP:0002113) | 2.18754471 |
84 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.17312108 |
85 | Eosinophilia (HP:0001880) | 2.17027345 |
86 | Bone pain (HP:0002653) | 2.16956775 |
87 | T lymphocytopenia (HP:0005403) | 2.16601340 |
88 | Medulloblastoma (HP:0002885) | 2.16451015 |
89 | Arterial thrombosis (HP:0004420) | 2.16203457 |
90 | Facial diplegia (HP:0001349) | 2.14432690 |
91 | Muscle fiber inclusion bodies (HP:0100299) | 2.14284401 |
92 | Leukocytosis (HP:0001974) | 2.14170151 |
93 | Meningitis (HP:0001287) | 2.13430045 |
94 | Increased cerebral lipofuscin (HP:0011813) | 2.12654435 |
95 | Glomerulonephritis (HP:0000099) | 2.11704122 |
96 | Abnormal hair whorl (HP:0010721) | 2.11569733 |
97 | Chronic diarrhea (HP:0002028) | 2.10793661 |
98 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.09525996 |
99 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09326598 |
100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09088766 |
101 | Osteolytic defects of the hand bones (HP:0009699) | 2.09088766 |
102 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.08090233 |
103 | Gastrointestinal carcinoma (HP:0002672) | 2.08090233 |
104 | Lip pit (HP:0100267) | 2.05632708 |
105 | Pathologic fracture (HP:0002756) | 2.05304140 |
106 | Nephritis (HP:0000123) | 2.04547435 |
107 | Dyschromatopsia (HP:0007641) | 2.04215954 |
108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03647156 |
109 | Abnormal biliary tract morphology (HP:0012440) | 2.01262431 |
110 | Clitoromegaly (HP:0000057) | 2.00335930 |
111 | Esophageal varix (HP:0002040) | 1.98888889 |
112 | Abnormality of the hepatic vasculature (HP:0006707) | 1.98661834 |
113 | Cerebral aneurysm (HP:0004944) | 1.98261993 |
114 | Capillary hemangiomas (HP:0005306) | 1.98250015 |
115 | Pulmonary artery stenosis (HP:0004415) | 1.98134819 |
116 | Abnormality of abdominal situs (HP:0011620) | 1.97459843 |
117 | Abdominal situs inversus (HP:0003363) | 1.97459843 |
118 | Abnormality of male internal genitalia (HP:0000022) | 1.95713734 |
119 | Joint hemorrhage (HP:0005261) | 1.95021388 |
120 | Skull defect (HP:0001362) | 1.94817297 |
121 | Spinal cord lesions (HP:0100561) | 1.94694164 |
122 | Syringomyelia (HP:0003396) | 1.94694164 |
123 | Abnormality of the right ventricle (HP:0001707) | 1.94142012 |
124 | Hemoptysis (HP:0002105) | 1.94110224 |
125 | Abnormal spermatogenesis (HP:0008669) | 1.93842409 |
126 | Keratoconjunctivitis sicca (HP:0001097) | 1.92636188 |
127 | Tetraparesis (HP:0002273) | 1.92172449 |
128 | Disinhibition (HP:0000734) | 1.90076793 |
129 | Distal lower limb amyotrophy (HP:0008944) | 1.90035803 |
130 | Amaurosis fugax (HP:0100576) | 1.89368873 |
131 | Clubbing of toes (HP:0100760) | 1.88152453 |
132 | Type I transferrin isoform profile (HP:0003642) | 1.87507239 |
133 | Dysostosis multiplex (HP:0000943) | 1.87313624 |
134 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.87078641 |
135 | Single umbilical artery (HP:0001195) | 1.87078641 |
136 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.87078641 |
137 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86814066 |
138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86814066 |
139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86814066 |
140 | Thyroiditis (HP:0100646) | 1.85156937 |
141 | Keratoconjunctivitis (HP:0001096) | 1.84955873 |
142 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84744133 |
143 | Submucous cleft hard palate (HP:0000176) | 1.84054274 |
144 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.83130366 |
145 | Azoospermia (HP:0000027) | 1.82669516 |
146 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.81909621 |
147 | Abnormality of T cell number (HP:0011839) | 1.81883485 |
148 | Thyroid carcinoma (HP:0002890) | 1.81427533 |
149 | Agnosia (HP:0010524) | 1.81312617 |
150 | Chronic otitis media (HP:0000389) | 1.81053634 |
151 | Neoplasm of the rectum (HP:0100743) | 1.81039763 |
152 | Spondylolisthesis (HP:0003302) | 1.79072474 |
153 | Hepatoblastoma (HP:0002884) | 1.78350816 |
154 | Right ventricular cardiomyopathy (HP:0011663) | 1.78076808 |
155 | Selective tooth agenesis (HP:0001592) | 1.77842158 |
156 | Neoplasm of the colon (HP:0100273) | 1.77627474 |
157 | Hypochromic microcytic anemia (HP:0004840) | 1.77048418 |
158 | Arterial tortuosity (HP:0005116) | 1.76876653 |
159 | Ascites (HP:0001541) | 1.75964705 |
160 | Narrow palate (HP:0000189) | 1.75959517 |
161 | Abnormal lung lobation (HP:0002101) | 1.75173932 |
162 | Neoplasm of the oral cavity (HP:0100649) | 1.75004541 |
163 | Increased IgM level (HP:0003496) | 1.74974881 |
164 | Short hallux (HP:0010109) | 1.74922139 |
165 | Abnormality of the columella (HP:0009929) | 1.74874979 |
166 | Intestinal fistula (HP:0100819) | 1.73486562 |
167 | Spontaneous hematomas (HP:0007420) | 1.73388295 |
168 | Rhinitis (HP:0012384) | 1.71860687 |
169 | Long foot (HP:0001833) | 1.71611755 |
170 | Bronchitis (HP:0012387) | 1.71060368 |
171 | Albinism (HP:0001022) | 1.70275823 |
172 | Fused cervical vertebrae (HP:0002949) | 1.70126110 |
173 | Carpal bone hypoplasia (HP:0001498) | 1.70011669 |
174 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.69991198 |
175 | Urticaria (HP:0001025) | 1.69436229 |
176 | Embryonal neoplasm (HP:0002898) | 1.69031753 |
177 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.68767899 |
178 | Abnormality of the basal ganglia (HP:0002134) | 1.66563731 |
179 | Short middle phalanx of the 5th finger (HP:0004220) | 1.66491981 |
180 | Prolonged bleeding time (HP:0003010) | 1.66213811 |
181 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65438142 |
182 | Mucopolysacchariduria (HP:0008155) | 1.65438142 |
183 | Hydroxyprolinuria (HP:0003080) | 1.65265814 |
184 | Cone-rod dystrophy (HP:0000548) | 1.64901790 |
185 | Uterine neoplasm (HP:0010784) | 1.64040875 |
186 | Abnormality of the labia minora (HP:0012880) | 1.63388263 |
187 | Acute lymphatic leukemia (HP:0006721) | 1.62798587 |
188 | Aortic aneurysm (HP:0004942) | 1.62519032 |
189 | Muscle fiber splitting (HP:0003555) | 1.62463439 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.93755544 |
2 | RIPK4 | 3.51641925 |
3 | ACVR1B | 3.45986106 |
4 | IRAK3 | 3.21584390 |
5 | IRAK4 | 2.89916426 |
6 | CDK12 | 2.75632059 |
7 | TGFBR2 | 2.74162762 |
8 | BRSK2 | 2.25875215 |
9 | TIE1 | 2.22799038 |
10 | EIF2AK3 | 2.21748655 |
11 | PIK3CG | 2.21125177 |
12 | TXK | 2.17638576 |
13 | TTK | 2.15185788 |
14 | BLK | 2.09252502 |
15 | CAMK1D | 2.06652549 |
16 | TYK2 | 2.06272657 |
17 | MAP3K13 | 1.95034933 |
18 | MKNK2 | 1.92025626 |
19 | NLK | 1.85683277 |
20 | JAK1 | 1.83272037 |
21 | IKBKE | 1.75625418 |
22 | OBSCN | 1.73603727 |
23 | JAK3 | 1.73471258 |
24 | SIK3 | 1.73271984 |
25 | PLK4 | 1.72938689 |
26 | SIK2 | 1.72589660 |
27 | FGR | 1.72335649 |
28 | CAMK1G | 1.65872054 |
29 | MKNK1 | 1.65650617 |
30 | MAP3K12 | 1.64962240 |
31 | GRK7 | 1.64702384 |
32 | IKBKB | 1.61734702 |
33 | KIT | 1.58085571 |
34 | CSK | 1.56880132 |
35 | TBK1 | 1.56060529 |
36 | TNIK | 1.51863221 |
37 | STK38L | 1.51284921 |
38 | TAF1 | 1.49290035 |
39 | TEC | 1.49014634 |
40 | STK24 | 1.48068299 |
41 | TAOK3 | 1.46489744 |
42 | MAP4K1 | 1.44526893 |
43 | TGFBR1 | 1.37697873 |
44 | YES1 | 1.33877899 |
45 | HCK | 1.32032273 |
46 | FLT3 | 1.30698236 |
47 | PLK3 | 1.30268871 |
48 | CHUK | 1.26738984 |
49 | FGFR3 | 1.24147576 |
50 | CSF1R | 1.20328903 |
51 | ZAK | 1.19678619 |
52 | BMPR2 | 1.19273617 |
53 | SCYL2 | 1.18219946 |
54 | NUAK1 | 1.17369785 |
55 | INSRR | 1.16124317 |
56 | MYLK | 1.15719720 |
57 | MARK3 | 1.15101839 |
58 | TRPM7 | 1.14741091 |
59 | STK10 | 1.10997500 |
60 | MATK | 1.08858361 |
61 | EIF2AK2 | 1.08500152 |
62 | ITK | 1.07842988 |
63 | MELK | 1.05619401 |
64 | CDC7 | 1.04730025 |
65 | CDK6 | 1.04460021 |
66 | NEK9 | 1.03168773 |
67 | OXSR1 | 1.00483900 |
68 | BRD4 | 0.99209387 |
69 | FRK | 0.98283529 |
70 | FES | 0.97920888 |
71 | MAP3K6 | 0.97792554 |
72 | MAPK7 | 0.97353919 |
73 | LYN | 0.93862565 |
74 | SGK3 | 0.93501453 |
75 | PBK | 0.91587569 |
76 | SRPK1 | 0.90266604 |
77 | SGK2 | 0.89584762 |
78 | EPHA3 | 0.88096750 |
79 | WNK3 | 0.84835366 |
80 | LCK | 0.84835055 |
81 | ERN1 | 0.83116949 |
82 | STK39 | 0.82259807 |
83 | PIM1 | 0.79901326 |
84 | LATS1 | 0.79459895 |
85 | SYK | 0.79200362 |
86 | PLK1 | 0.78963578 |
87 | JAK2 | 0.78663745 |
88 | CDK19 | 0.78445922 |
89 | ADRBK2 | 0.78270576 |
90 | ERBB4 | 0.77063914 |
91 | PRPF4B | 0.77003615 |
92 | EPHB1 | 0.76034008 |
93 | CAMK4 | 0.75041006 |
94 | ATM | 0.74766745 |
95 | ZAP70 | 0.74046919 |
96 | SIK1 | 0.72820623 |
97 | TSSK6 | 0.72076639 |
98 | CLK1 | 0.70337668 |
99 | STK3 | 0.68848734 |
100 | CDK9 | 0.68469682 |
101 | AKT3 | 0.67260678 |
102 | MAP2K3 | 0.66845180 |
103 | MET | 0.66615803 |
104 | FER | 0.66280067 |
105 | BUB1 | 0.66046152 |
106 | EGFR | 0.65065761 |
107 | ERBB3 | 0.64787778 |
108 | STK4 | 0.64200122 |
109 | BTK | 0.63844590 |
110 | PRKAA2 | 0.63596467 |
111 | SGK1 | 0.62796722 |
112 | RPS6KA4 | 0.59500942 |
113 | MAPK15 | 0.58653335 |
114 | PAK4 | 0.57448131 |
115 | DYRK3 | 0.56848718 |
116 | TTN | 0.56664794 |
117 | MST4 | 0.55787549 |
118 | ABL1 | 0.55432705 |
119 | PNCK | 0.54384598 |
120 | MAP3K10 | 0.53488237 |
121 | BMX | 0.53338874 |
122 | PLK2 | 0.52686503 |
123 | PDGFRB | 0.50911254 |
124 | STK16 | 0.49774011 |
125 | PRKCQ | 0.49527452 |
126 | CHEK2 | 0.47739117 |
127 | DMPK | 0.45228795 |
128 | IRAK1 | 0.44823868 |
129 | MOS | 0.44591543 |
130 | DAPK2 | 0.44336305 |
131 | IGF1R | 0.44234341 |
132 | CASK | 0.44174376 |
133 | PKN1 | 0.44148185 |
134 | PIK3CA | 0.43845732 |
135 | DDR2 | 0.43407998 |
136 | PRKD2 | 0.42210944 |
137 | BMPR1B | 0.42138103 |
138 | RIPK1 | 0.40248663 |
139 | GRK1 | 0.39914472 |
140 | WNK1 | 0.39755218 |
141 | PRKG2 | 0.39297065 |
142 | PTK6 | 0.39199001 |
143 | CDK3 | 0.39176614 |
144 | PRKCD | 0.38708745 |
145 | VRK1 | 0.38078230 |
146 | FGFR1 | 0.37730779 |
147 | CHEK1 | 0.37653776 |
148 | EEF2K | 0.37115097 |
149 | INSR | 0.36925333 |
150 | ATR | 0.35691152 |
151 | MAP3K8 | 0.35586117 |
152 | PDGFRA | 0.35347536 |
153 | CAMKK2 | 0.34388347 |
154 | RPS6KB2 | 0.33084346 |
155 | RPS6KA6 | 0.32890281 |
156 | KDR | 0.31816229 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.43912316 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 3.00475728 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61775525 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56422622 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46224750 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.45218093 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42732485 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.32112923 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.15505328 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11740601 |
11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04675632 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.89361614 |
13 | DNA replication_Homo sapiens_hsa03030 | 1.89029224 |
14 | Tuberculosis_Homo sapiens_hsa05152 | 1.88871314 |
15 | RNA degradation_Homo sapiens_hsa03018 | 1.82803774 |
16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.79614791 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78793826 |
18 | Measles_Homo sapiens_hsa05162 | 1.78619451 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77057401 |
20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73107758 |
21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.70396209 |
22 | Malaria_Homo sapiens_hsa05144 | 1.69863527 |
23 | Pertussis_Homo sapiens_hsa05133 | 1.67052772 |
24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65935741 |
25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65269636 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63936094 |
27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61736669 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.60398920 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60164071 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55942141 |
31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.54513971 |
32 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.51341187 |
33 | Proteasome_Homo sapiens_hsa03050 | 1.50523196 |
34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.50516950 |
35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50252042 |
36 | RNA transport_Homo sapiens_hsa03013 | 1.48444473 |
37 | Legionellosis_Homo sapiens_hsa05134 | 1.46334530 |
38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45764649 |
39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45743400 |
40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.42767134 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41278139 |
42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40463048 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.40432585 |
44 | Cell cycle_Homo sapiens_hsa04110 | 1.39677411 |
45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38139618 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34725891 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33805366 |
48 | Allograft rejection_Homo sapiens_hsa05330 | 1.32913214 |
49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32749405 |
50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.32667095 |
51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31913083 |
52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29563630 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27488792 |
54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.25986725 |
55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24875064 |
56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22449610 |
57 | Lysosome_Homo sapiens_hsa04142 | 1.21459144 |
58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20653503 |
59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20078176 |
60 | Salmonella infection_Homo sapiens_hsa05132 | 1.16658788 |
61 | Phagosome_Homo sapiens_hsa04145 | 1.15722374 |
62 | Asthma_Homo sapiens_hsa05310 | 1.15229008 |
63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13267576 |
64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13029878 |
65 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13010775 |
66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09268561 |
67 | Hepatitis B_Homo sapiens_hsa05161 | 1.09218208 |
68 | Base excision repair_Homo sapiens_hsa03410 | 1.06758804 |
69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06680245 |
70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05970732 |
71 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05869553 |
72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05035261 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01711029 |
74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99689194 |
75 | Apoptosis_Homo sapiens_hsa04210 | 0.99001177 |
76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98979140 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98817485 |
78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97696716 |
79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94909316 |
80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94585474 |
81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93918275 |
82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93512547 |
83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93464328 |
84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92299350 |
85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92078372 |
86 | Adherens junction_Homo sapiens_hsa04520 | 0.91454650 |
87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90901382 |
88 | Tight junction_Homo sapiens_hsa04530 | 0.90769699 |
89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.90475747 |
90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90126105 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.89326240 |
92 | Hepatitis C_Homo sapiens_hsa05160 | 0.87300472 |
93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87280415 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86653689 |
95 | Shigellosis_Homo sapiens_hsa05131 | 0.86592647 |
96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85927594 |
97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85408309 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84969006 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82574196 |
100 | Platelet activation_Homo sapiens_hsa04611 | 0.82486832 |
101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82213265 |
102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81559875 |
103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.81412654 |
104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81251989 |
105 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80380847 |
106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79010147 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78686869 |
108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77877333 |
109 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76858947 |
110 | Protein export_Homo sapiens_hsa03060 | 0.76446848 |
111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75057035 |
112 | Lysine degradation_Homo sapiens_hsa00310 | 0.74734924 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.72765146 |
114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68028869 |
115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67607952 |
116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67307909 |
117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66699105 |
118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66134776 |
119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65201392 |
120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61778710 |
121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61543626 |
122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60610005 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.59882757 |
124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59294861 |
125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58234320 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58202400 |
127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57091299 |
128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55427317 |
129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54093666 |
130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53321579 |
131 | Renin secretion_Homo sapiens_hsa04924 | 0.53100583 |
132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52725739 |
133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51858024 |
134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51093799 |
135 | Focal adhesion_Homo sapiens_hsa04510 | 0.50600399 |
136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50375206 |
137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49980670 |
138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49028558 |
139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48909089 |
140 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47687624 |
141 | Insulin resistance_Homo sapiens_hsa04931 | 0.46967679 |
142 | Purine metabolism_Homo sapiens_hsa00230 | 0.46910232 |
143 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46478660 |
144 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46031363 |
145 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45235110 |
146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45206915 |
147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44999707 |
148 | Melanoma_Homo sapiens_hsa05218 | 0.44400970 |
149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44255499 |
150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44187720 |
151 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42970145 |
152 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42816545 |
153 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42511023 |
154 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41968636 |
155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41198597 |
156 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41068606 |
157 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40651246 |
158 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37803754 |
159 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37360512 |
160 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37252872 |
161 | RNA polymerase_Homo sapiens_hsa03020 | 0.36085332 |